Rodman & Renshaw Initiates Coverage On Leap Therapeutics With Buy Rating, Announces Price Target of $8
Rodman & Renshaw Initiates Coverage On Leap Therapeutics With Buy Rating, Announces Price Target of $8
Rodman＆Renshaw以買入評級開始覆蓋Leap Therapeutics，宣佈8美元的目標價。
Rodman & Renshaw analyst Tony Butler initiates coverage on Leap Therapeutics (NASDAQ:LPTX) with a Buy rating and announces Price Target of $8.
羅德曼與倫敦分析師託尼·巴特勒（Tony Butler）開始對Leap Therapeutics（NASDAQ：LPTX）進行覆蓋，將其評爲買入，宣佈目標價爲8美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。